COGT
Cogent Biosciences·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
COGT fundamentals
Cogent Biosciences (COGT) released its earnings on Nov 3, 2025: revenue was -- (YoY 0.00%), beat estimates; EPS was -0.5 (YoY +21.88%), beat estimates.
Revenue / YoY
--
0.00%
EPS / YoY
-0.5
+21.88%
Report date
Nov 3, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Cogent Biosciences (COGT) key financial stats and ratios, covering profitability, financial health, and leverage.
Cogent Biosciences (COGT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Cogent Biosciences (COGT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cogent Biosciences (COGT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Cogent Biosciences (COGT) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Cogent Biosciences (COGT) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Cogent Biosciences's gross profit margin?What factors drove the changes in Cogent Biosciences's revenue and profit?What guidance did Cogent Biosciences's management provide for the next earnings period?What were the key takeaways from Cogent Biosciences’s earnings call?What is the market's earnings forecast for Cogent Biosciences next quarter?What is the revenue and EPS growth rate for Cogent Biosciences year over year?Did Cogent Biosciences beat or miss consensus estimates last quarter?What is Cogent Biosciences's latest dividend and current dividend yield?
